Mosaicism for Dominant Collagen 6 Mutations as a Cause for Intrafamilial Phenotypic Variability

Collagen 6‐related dystrophies and myopathies (COL6‐RD) are a group of disorders that form a wide phenotypic spectrum, ranging from severe Ullrich congenital muscular dystrophy, intermediate phenotypes, to the milder Bethlem myopathy. Both inter‐ and intrafamilial variable expressivity are commonly observed. We present clinical, immunohistochemical, and genetic data on four COL6‐RD families with marked intergenerational phenotypic heterogeneity. This variable expression seemingly masquerades as anticipation is due to parental mosaicism for a dominant mutation, with subsequent full inheritance and penetrance of the mutation in the heterozygous offspring. We also present an additional fifth simplex patient identified as a mosaic carrier. Parental mosaicism was confirmed in the four families through quantitative analysis of the ratio of mutant versus wild‐type allele (COL6A1, COL6A2, and COL6A3) in genomic DNA from various tissues, including blood, dermal fibroblasts, and saliva. Consistent with somatic mosaicism, parental samples had lower ratios of mutant versus wild‐type allele compared with the fully heterozygote offspring. However, there was notable variability of the mutant allele levels between tissues tested, ranging from 16% (saliva) to 43% (fibroblasts) in one mosaic father. This is the first report demonstrating mosaicism as a cause of intrafamilial/intergenerational variability of COL6‐RD, and suggests that sporadic and parental mosaicism may be more common than previously suspected.

[1]  K. Bushby,et al.  Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. , 2014, Human molecular genetics.

[2]  M. Devoto,et al.  Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice. , 2014, Human molecular genetics.

[3]  C. Bönnemann,et al.  siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy , 2014, Molecular therapy. Nucleic acids.

[4]  R. Weiss,et al.  Position of Glycine Substitutions in the Triple Helix of COL6A1, COL6A2, and COL6A3 is Correlated with Severity and Mode of Inheritance in Collagen VI Myopathies , 2013, Human mutation.

[5]  S. Holland,et al.  Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. , 2013, The Journal of allergy and clinical immunology.

[6]  A. Ferlini,et al.  Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy. , 2012, Human gene therapy.

[7]  C. Bönnemann The collagen VI-related myopathies: muscle meets its matrix , 2011, Nature Reviews Neurology.

[8]  P. Byers,et al.  Recurrence of perinatal lethal osteogenesis imperfecta in sibships: Parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance , 2011, Genetics in Medicine.

[9]  Marni J. Falk,et al.  Large genomic deletions: A novel cause of Ullrich congenital muscular dystrophy , 2011, Annals of neurology.

[10]  E. Bertini,et al.  Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation , 2010, Neuromuscular Disorders.

[11]  E. Hoffman,et al.  Somatic mosaicism for Duchenne dystrophy: Evidence for genetic normalization mitigating muscle symptoms , 2009, American journal of medical genetics. Part A.

[12]  N. Clarke,et al.  Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy , 2009, Neuromuscular Disorders.

[13]  B. Ceulemans,et al.  Molecular consequences of dominant Bethlem myopathy collagen VI mutations , 2007, Annals of neurology.

[14]  E. Bertini,et al.  Ullrich myopathy phenotype with secondary ColVI defect identified by confocal imaging and electron microscopy analysis , 2007, Neuromuscular Disorders.

[15]  Susan C. Brown,et al.  A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations , 2006, Neuromuscular Disorders.

[16]  J. Allsop,et al.  Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Neuromuscular Disorders.

[17]  K. North,et al.  Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. , 2004, Human molecular genetics.

[18]  F. Hanefeld,et al.  Muscle ultrasound in Bethlem myopathy. , 2003, Neuropediatrics.

[19]  R. Hofstra,et al.  Detection of point mutation in dystrophin gene reveals somatic and germline mosaicism in the mother of a patient with Duchenne muscular dystrophy , 2003, American journal of medical genetics. Part A.

[20]  A. Polo,et al.  A somatic and germline mosaic mutation in MPZ/P0 mimics recessive inheritance of CMT1B , 2001, Neurology.

[21]  K. Pelin,et al.  Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy , 1999, Nature Genetics.

[22]  B. Gallie,et al.  Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. , 1998, American journal of human genetics.

[23]  H. Sørensen,et al.  Research in Health Care , 1996 .

[24]  M. Upadhyaya,et al.  Inheritance of CMT1A duplication from a mosaic father. , 1995, Journal of medical genetics.

[25]  P. Byers,et al.  Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. , 1990, American journal of human genetics.

[26]  P. Byers,et al.  Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). , 1990, American journal of human genetics.